Literature DB >> 11792770

Peritoneal dialysis in the 21st century: an analysis of current problems and future developments.

Ram Gokal1.   

Abstract

Mesh：

Year:  2002        PMID： 11792770

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  17 in total

1.  Amelioration of ischemic brain damage by peritoneal dialysis.

Authors:  María del Carmen Godino; Victor G Romera; José Antonio Sánchez-Tomero; Jesus Pacheco; Santiago Canals; Juan Lerma; José Vivancos; María Angeles Moro; Magdalena Torres; Ignacio Lizasoain; José Sánchez-Prieto
Journal:  J Clin Invest       Date:  2013-09-03       Impact factor: 14.808

2.  Rosiglitazone, a Peroxisome Proliferator-Activated Receptor (PPAR)-γ Agonist, Attenuates Inflammation Via NF-κB Inhibition in Lipopolysaccharide-Induced Peritonitis.

Authors:  Yun-Fang Zhang; Xun-Liang Zou; Jun Wu; Xue-Qing Yu; Xiao Yang
Journal:  Inflammation       Date:  2015-12       Impact factor: 4.092

3.  Glucose-based peritoneal dialysis fluids downregulate toll-like receptors and trigger hyporesponsiveness to pathogen-associated molecular patterns in human peritoneal mesothelial cells.

Authors:  Jun Wu; Xiao Yang; Yun-Fang Zhang; Ya-Ning Wang; Mei Liu; Xiu-Qing Dong; Jin-Jin Fan; Xue-Qing Yu
Journal:  Clin Vaccine Immunol       Date:  2010-03-03

Review 4.  Can peritoneal dialysis be used as a long term therapy for end stage renal disease?

Authors:  Michele Giannattasio; Michele Buemi; Flavia Caputo; Giusto Viglino; Enrico Verrina
Journal:  Int Urol Nephrol       Date:  2003       Impact factor: 2.370

5.  Angiotensin II upregulates Toll-like receptor 4 and enhances lipopolysaccharide-induced CD40 expression in rat peritoneal mesothelial cells.

Authors:  Jun Wu; Xiao Yang; Yun-Fang Zhang; Shu-Feng Zhou; Rui Zhang; Xiu-Qing Dong; Jin-Jin Fan; Mei Liu; Xue-Qing Yu
Journal:  Inflamm Res       Date:  2009-03-07       Impact factor: 4.575

6.  Long-term efficacy of intermittent peritoneal dialysis using various doses.

Authors:  Zhi-Yong Zhang; Chun-Hua Zhou; Ming-Xu Li; Yong-Wu Yu
Journal:  Exp Ther Med       Date:  2011-12-30       Impact factor: 2.447

Review 7.  Icodextrin: a review of its use in peritoneal dialysis.

Authors:  James E Frampton; Greg L Plosker
Journal:  Drugs       Date:  2003       Impact factor: 9.546

8.  Perspectives of patients, families, and health care professionals on decision-making about dialysis modality--the good, the bad, and the misunderstandings!

Authors:  Konstadina Griva; Zhi Hui Li; Alden Yuanhong Lai; Meng Chan Choong; Marjorie Wai Yin Foo
Journal:  Perit Dial Int       Date:  2012-11-01       Impact factor: 1.756

9.  Nitric oxide synthase isoforms play distinct roles during acute peritonitis.

Authors:  Jie Ni; Rachel M McLoughlin; Alexandre Brodovitch; Pierre Moulin; Peter Brouckaert; Barbara Casadei; Olivier Feron; Nicholas Topley; Jean-Luc Balligand; Olivier Devuyst
Journal:  Nephrol Dial Transplant       Date:  2009-08-25       Impact factor: 5.992

10.  Comparing Survival between peritoneal dialysis and hemodialysis patients with subclinical peripheral artery disease: a 6-year follow-up.

Authors:  Jiung-Hsiun Liu; Jan-Yow Chen; Shih-Yi Lin; Hsin-Hung Lin; I-Wen Ting; Chih-Chia Liang; I-Kuan Wang; Huey-Liang Kuo; Chiz-Tzung Chang; Chiu-Ching Huang; Fung-Chang Sung
Journal:  Int J Med Sci       Date:  2013-03-01       Impact factor: 3.738
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.